# SUFLAVE
> **NDA215344** · New Drug Application · Sponsor: AZURITY · Approved 2023-06-15
## Drug
- **FDA Application Number:** NDA215344
- **Application type:** New Drug Application
- **Brand name:** SUFLAVE
- **Generic name:** POLYETHYLENE GLYCOL 3350, SODIUM SULFATE, POTASSIUM CHLORIDE, MAGNESIUM SULFATE, AND SODIUM CHLORIDE FOR ORAL SOLUTION
- **Active ingredients:** MAGNESIUM SULFATE; POLYETHYLENE GLYCOL 3350; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM SULFATE
- **Dosage form:** FOR SOLUTION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** AZURITY
- **Manufacturer:** Braintree Laboratories, Inc.
- **First approval:** 2023-06-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215344)
---
*MORVS · CC0 1.0*